Chronic Pain? Melatonin May Provide Some Relief, Study Finds

Recent research has revealed that melatonin, a hormone commonly associated with regulating sleep patterns, may also relieve chronic musculoskeletal pain to a degree comparable to over-the-counter pain relievers such as ibuprofen and aspirin. This finding opens up new avenues for pain management, particularly for individuals suffering from chronic pain.

The study, published in the journal *PAIN*, highlights the potential benefits of melatonin for those experiencing chronic pain—defined as pain lasting three months or longer. While the evidence for its effectiveness in alleviating post-surgical pain was less definitive, the results suggest that melatonin may serve as a valuable adjunct to existing pain treatments, especially for those who also struggle with sleep disturbances.

Chronic pain and sleep issues often exacerbate each other. Pain can disrupt sleep, which in turn can amplify the perception of pain. This reciprocal relationship has led researchers to explore melatonin’s dual role in enhancing sleep quality and potentially reducing pain.

Lead researcher Kangchao Wu, a PhD candidate at the University of Sydney, explained that melatonin may have intrinsic pain-relieving properties, thanks to its antioxidant and anti-inflammatory effects. Additionally, improved sleep from melatonin can enhance overall well-being, reduce anxiety and depression related to pain, and encourage greater daytime activity, all of which can contribute to a decrease in pain intensity.

However, the effectiveness of melatonin appears to vary depending on the type of pain. Chronic musculoskeletal pain, often linked to long-term conditions like inflammation and nervous system sensitivity, responded better to melatonin compared to acute post-operative pain, which typically arises from surgical procedures.

Wu emphasized that melatonin should not replace existing pain treatments but could complement them, particularly for those dealing with sleep issues. He advises anyone considering melatonin for pain management to consult with a healthcare provider, especially if they are not currently experiencing sleep problems or are on other medications.

In terms of dosage, the study indicated that short-term use—less than three months at doses of up to 5 milligrams—is generally safe. Most trials reviewed in the study utilized a dose of 3 milligrams, which appeared to be effective without significant side effects. While melatonin is generally well-tolerated, potential side effects can include headaches, nausea, and daytime drowsiness, although these were reported at rates similar to those in placebo groups.

Notably, melatonin is not recommended for pregnant or nursing individuals, nor for those with certain health conditions such as kidney or liver diseases, without prior discussion with a healthcare professional.

As sleep deprivation remains a prevalent issue, with nearly 37% of U.S. adults not meeting the recommended seven hours of sleep, this research suggests that melatonin may offer more than just a sleep aid. However, it is essential to recognize that the FDA does not regulate melatonin supplements as strictly as medications, underscoring the importance of professional guidance in their use.

In summary, while melatonin shows promise for alleviating chronic pain, it is crucial for individuals to engage in conversations with their healthcare providers to ensure safe and effective use tailored to their specific health needs.